Services

Remicade® (infliximab) and Entyvio® (vedolizumab) Infusions

Remicade (infliximab) and Entyvio (vedolizumab) are treatment options available for Chrohn's disease and ulcerative colitis.

Remicade® and EnTyvio® are property of their respective owners. Please see the respective manufacturer's website for more information.